Galliprant: Product Information (Page 3 of 5)

Storage Conditions:

Store at or below 86° F (30° C)

How Supplied:

20 mg, 60 mg and 100 mg flavored tablets in 7, 30 and 90 count bottles

Approved by FDA under NADA # 141-455

Manufactured for:
Elanco US Inc.
Greenfield, IN 46140

References:

1.
Nakao, K., Murase, A., et al. CJ-023,423, a novel, potent and selective prostaglandin EP4 receptor antagonist with antihyperalgesic properties. The Journal of Pharmacology and Experimental Therapeutics. 2007; 322(2), 686-694.
2.
Murase, A., Okumura, T., et al. Effect of prostanoid EP4 receptor antagonist, CJ-042,794, in rat models of pain and inflammation. European Journal of Pharmacology. 2008; 580(1-2), 116-121.
3.
Takeuchi, K., S. Kato, et al. Prostaglandin EP receptors involved in modulating gastrointestinal mucosal integrity. Journal of Pharmacological Sciences. 2010; 114(3): 248-261.
4.
Hatazawa R, Tanaka A, Tanigami M, et al. Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2007; 293: G788-G797.
5.
Nasrallah R, Hassouneh R, and Hebert R. Chronic kidney disease: targeting prostaglandin E2 receptors. American Journal of Physiology Renal Physiology. 2014; 307: F242-250.
6.
Castleberry TA, Lu B, et al. Molecular cloning and functional characterization of the canine prostaglandin E2 receptor EP4 subtype. Prostaglandins and Other Lipid Mediators. 2001; 65: 167-187.
7.
http://www.vet.upenn.edu/docs/default-source/ VCIC/canine-bpi_userguide. pdf?sfvrsn=0

Galliprant is the registered trademark of Aratana Therapeutics, Inc.

Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

© 2022 Elanco or its affiliates

November 2022
PA103754X

ARATANA
THERAPEUTICS®

Elanco TM
Galliprant®
(grapiprant tablets)

For oral use in dogs only

Flavored tablets

A prostaglandin E2 (PGE2 ) EP4 receptor antagonist; a non-cyclooxygenase inhibiting, non-steroidal, anti-inflammatory drug.

Information for Dog Owners

GALLIPRANT is indicated for the control of pain and inflammation due to osteoarthritis.

This sheet contains important information about GALLIPRANT.

You should read this information before starting your dog on GALLIPRANT and review it each time the prescription is refilled. This information provides a summary and does not take the place of the instructions from your veterinarian. Talk to your veterinarian if you do not understand any of this information or you want more information about GALLIPRANT.

GALLIPRANT is a prostaglandin E2 (PGE2 ) EP4 receptor antagonist; a non-cyclooxygenase (COX) inhibiting, non-steroidal, anti-inflammatory drug (NSAID). As an anti-inflammatory, GALLIPRANT is indicated for the control of pain and inflammation associated with osteoarthritis in dogs.

Control of pain and inflammation may vary from dog to dog. Consult your veterinarian if your dog appears to be uncomfortable. GALLIPRANT may need to be given for an extended period of time. Use the lowest dose to provide adequate pain control. Always consult with your veterinarian before altering the dose.

It is important to periodically discuss your dog’s response to GALLIPRANT with your veterinarian. Your veterinarian will discuss appropriate monitoring while your dog is on GALLIPRANT.

The most common side effects associated with GALLIPRANT include vomiting, soft, mucoid stools, diarrhea and decreased appetite. You should contact your veterinarian if your dog’s appetite decreases or stools become abnormal.

Dogs should not take GALLIPRANT if:

Your dog is presently taking aspirin, other NSAIDs, or corticosteroids (unless directed by your veterinarian).
Your dog has had an allergic reaction (such as hives, facial swelling, or itchy skin) to GALLIPRANT. Inform your veterinarian if your dog has had an allergic reaction to other anti-inflammatory drugs.
Your dog is under 8 pounds in body weight.

GALLIPRANT should only be given to dogs. Do not use in cats.

GALLIPRANT should not be given with other non-steroidal anti-inflammatory drugs (NSAIDs) or corticosteroids (for example, aspirin, carprofen, meloxicam and prednisone).

Not for use in humans. Keep this and all medications out of reach of children and pets. Consult a physician in case of accidental ingestion by humans.

Store GALLIPRANT out of reach of dogs and other pets in a secured location in order to prevent accidental ingestion or overdose.

Tell your veterinarian about:

Any side effects your dog has experienced from GALLIPRANT or other NSAIDs.
Any digestive issues (bloody, mucoid stool, vomiting or diarrhea, or decreased appetite) your dog has.
Any other medical problems or allergies that your dog has had.
All medications that you are giving your dog or plan to give your dog, including those you can get without a prescription and any dietary supplements.
If you plan to breed your dog, or if your dog is pregnant or nursing.

If you have additional questions about possible side effects while your dog is on GALLIPRANT, talk with your veterinarian or call 1-888-545-5973.

Galliprant is the registered trademark of Aratana Therapeutics, Inc.

Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

November 2022

ARATANA
THERAPEUTICS®

PA103754X

Elanco TM

Principal Display Panel — Galliprant 20 mg 7 Tablets Carton Label

Galliprant ®

(grapiprant tablets)

20 mg

For oral use
in dogs only

EP4 Prostaglandin

Receptor Antagonist NSAID

Caution: Federal (USA)
law restricts this drug to
use by or on the order of
a licensed veterinarian.

7
FLAVORED
TABLETS

ARATANATHERAPEUTICS®

Elanco

Principal Display Panel -- Galliprant 20 mg 7 Tablets Carton Label
(click image for full-size original)

Principal Display Panel — Galliprant 20 mg 7 Tablets Bottle Label

Galliprant ®

(grapiprant tablets)

20 mg

For oral use in dogs only

EP4 Prostaglandin

Receptor Antagonist NSAID

Caution: Federal (USA)
law restricts this drug to
use by or on the order of
a licensed veterinarian.

7
FLAVOREDTABLETS

Principal Display Panel -- Galliprant 20 mg 7 Tablets Bottle Label
(click image for full-size original)

Principal Display Panel — Galliprant 20 mg 30 Tablets Carton Label

Galliprant ®

(grapiprant tablets)

20 mg

For oral use
in dogs only

EP4 Prostaglandin

Receptor Antagonist NSAID

Caution: Federal (USA)
law restricts this drug to
use by or on the order of
a licensed veterinarian.

30
FLAVORED
TABLETS

ARATANATHERAPEUTICS®

Elanco

Principal Display Panel -- Galliprant 20 mg 30 Tablets Carton Label
(click image for full-size original)

Principal Display Panel — Galliprant 20 mg 30 Tablets Bottle Label

Galliprant ®

(grapiprant tablets)

20 mg

For oral use in dogs only

EP4 Prostaglandin

Receptor Antagonist NSAID

Caution: Federal (USA)
law restricts this drug to
use by or on the order of
a licensed veterinarian.

30
FLAVOREDTABLETS

Principal Display Panel -- Galliprant 20 mg 30 Tablets Bottle Label
(click image for full-size original)

VetLabel.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VetLabel.com. Every individual animal healthcare product label entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Our database mirrors the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. VetLabel.com provides the full animal health subset of the FDA's repository. Veterinary information provided here is not intended as a substitute for direct consultation with a qualified veterinary professional.

Terms of Use | Copyright © 2024. All Rights Reserved.